MDMA Given Green Light In Californian Therapy Trials

  • Words: Spindle Team
  • Photography: John Hartberg

The San Francisco Chronicle has reported that a team of San Francisco researchers will be exploring the benefits of MDMA in patients dealing with chronic anxiety and depression this June, in the first study of its kind to be jointly sanctioned by the FDA and DEA.

Principle investigator Dr. Philip Wolfson stated that the substance “supports deep, meaningful and rapidly effective psychotherapy” and that use of the drug in controlled sessions should “no longer be a fringe thing”.